Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
956624-58-1 | 3-(4-Ethylphenyl)-1-(o-tolyl)-1H-pyrazole-4-carboxylic acid | AA019JT1 | MFCD06655064
1049741-22-1 | [5-(piperidine-1-sulfonyl)thiophen-2-yl]methanamine hydrochloride | AA019K1G | MFCD09285232
923689-14-9 | 1-methyl-1H,2H,3H,4H-pyrazino[2,3-b]quinoxaline | AA019K88 | MFCD08689813
929975-29-1 | 2,4-Dimethyl-6-(methylthio)pyrimidine-5-carboxylic acid | AA019KD9 | MFCD09040412
929973-93-3 | 1-(6,7-Dihydro-5h-pyrrolo[2,1-c][1,2,4]triazol-3-yl)ethanamine | AA019KIO | MFCD09040605
1050883-91-4 | propan-2-yl 4-(2-chloropropanamido)benzoate | AA019KO3 | MFCD10686663
1087784-17-5 | 1-(4-aminophenyl)-3-(2-methoxyethyl)urea | AA019KTY | MFCD11505367
950070-03-8 | N-(2-aminoethyl)-3-fluoro-4-methylbenzamide | AA019KZG | MFCD09742599
1252036-94-4 | 2-(4-chlorophenyl)-2-(piperazin-1-yl)acetamide dihydrochloride | AA019L4P | MFCD18838618
956751-68-1 | 1-(2,4-dimethylphenyl)-3-phenyl-1H-pyrazol-5-amine | AA019L91 | MFCD08445055
Journal: Bioorganic & medicinal chemistry letters20101101